Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 1.070

0.0%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ace who wrote (9255)	5/8/1998 3:46:00 PM
From: Steve Stuart	of 14328

Yes, Trinity will book a gain from the SLF deal. They paid for their shares at about $3.25 apiece. I don't know if Irish GAAP rules match U.S. rules on this issue, but once they mark the shares at market value instead of cost, they will book a gain of roughly $.20 per share, depending on the market price of SLF. This will definitely be a one-time, non-recurring, non-cash gain. I suspect we will see no press release, as this is old news. The settlement was reached on March 6, and the SEC filing that disclosed it was filed on April 22. The reason it hasn't impacted the stock price is that management has hinted at the 80% settlement figure for the past few conference calls. The $.20 gain in assets was surely priced into the stock some time ago. -Steve Stuart

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next